Tranzactioneaza Adaptive Biotechnologies Corp (US.ADPT) - 5.525 USD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 5.2800 USD
Ask 5.6000 USD
Minim 5.0600 USD
Maxim 5.2800 USD
Pret referinta 5.0600
Volum -
Volum ultima zi 1
Max 52 sapt 5.5300 USD
Min 52 sapt 2.2800 USD

Descriere companie

Adaptive Biotechnologies Corporation (https://www.adaptivebiotech.com/) is a commercial-stage company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform combines a suite of chemistry, biology and machine learning to generate clinical immunomics data to decode the adaptive immune system. Its commercial research products include immunoSEQ and immunoSEQ T-MAP. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). Its clonoSEQ diagnostic test detects and monitors the number of cancer cells that are present in a patient’s body during and after treatment, known as minimal residual disease (MRD). It uses its T cell receptor (TCR)-Antigen Map to develop research solutions and diagnostic products, such as immunoSEQ T-MAP and T-Detect. It also focuses on developing immune-mediated therapies in oncology and other disease areas.

Informatii companie

Nume

ADAPTIVE BIOTECHNOLOGIES CORP